To provide these insights, Verilogue engaged in voice-enabled pulse surveys with healthcare professionals and analyzed 54 responses collected July 30 – August 3, 2020 Verilogue is chronicling the impact of COVID-19 across the care continuum, focusing on the shared experiences…

Improved compliance and adherence can lead to better health outcomes for patients and brand growth for drug manufacturers, but convincing patients to accept treatment is a well-recognized challenge.

Words matter—that’s why we do the work that we do at Verilogue. We all probably agree that having clear and effective communication is important, but even more than that, the very words we choose can subtly impact those with whom…

Today is #EqualPayDay. In honor of pay parity, we’re thinking about how doctors and patients navigate costs from our fly-on-the-wall perspective. Out of the 15,000+ dialogues we’ve collected in the United States over the last year, about 5,700 mention the…

When I work on pipeline products, I always find the moment when drug names are announced incredibly fascinating, not just because it feels like the launch of a product’s identity in a sense, but also because the nuances of the…

Marketing to the Pharma Sector can be quite challenging in today’s environment. Unlike normal B2B structures, these huge targets are comprised of some of the largest most profitable brands in the world, operating in arguably the most regulated sector imaginable.…